Tg Therapeutics (TGTX) Return on Equity [ROE] (2011 - 2026)
Tg Therapeutics (TGTX) reported Return on Equity [ROE] of 74.37% for Q2 2026, up 50.83 percentage points from 23.54% a year earlier but down 0.67 percentage points from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Tg Therapeutics posted Return on Equity [ROE] of 102.75%, up 90.54 percentage points from FY2024.
- Return on Equity [ROE] has increased for three consecutive years, with a five-year change of +202.90 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at 12.21% in FY2024 (+0.65 pp), 11.57% in FY2023 (+145.70 pp), -134.13% in FY2022 (-42.10 pp) and -92.03% in FY2021 (+8.11 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -517.50% in Q2 2023 and a high of 101.28% in Q3 2025.
- Year over year, Return on Equity [ROE] has now increased in each of the last four quarters, with an average year-over-year change of +32.13 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2024 (a gain of 574.17 percentage points); the low point was Q2 2023 (a drop of 324.79 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 75.03% (Q1 2026), 71.25% (Q4 2025) and 101.28% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Tg Therapeutics | 9.71 Bn | 8.96 Bn | 217.86 Mn | 18.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18.02% |
| Jun 30, 2026 | 74.37% |
| Mar 31, 2026 | 75.03% |
| Dec 31, 2025 | 71.25% |
| Sep 30, 2025 | 101.28% |
| Jun 30, 2025 | 23.54% |
| Mar 31, 2025 | 17.03% |
| Dec 31, 2024 | 11.28% |
| Sep 30, 2024 | -7.78% |
| Jun 30, 2024 | 56.67% |
| Mar 31, 2024 | 25.70% |
| Dec 31, 2023 | 7.79% |
| Sep 30, 2023 | -25.25% |
| Jun 30, 2023 | -517.50% |
| Mar 31, 2023 | -391.89% |
| Dec 31, 2022 | -249.37% |
| Sep 30, 2022 | -207.98% |
| Jun 30, 2022 | -192.70% |
| Mar 31, 2022 | -160.22% |
| Dec 31, 2021 | -126.89% |
API Access
Tg Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();